, the world's largest generic drugmaker, said its chief executive Jeremy Levin was stepping down and finance chief Eyal Desheh would stand in on an interim basis, effective immediately. Earlier this week, Teva and Levin denied an Israeli media report that Levin was considering resigning due to a rift with the company's board of directors. The board of Israel-based Teva "The board and management team are fully committed to the implementation of Teva's strategy, including the development of new compounds, making strategic acquisitions, forming joint ventures and the planned acceleration of the company's cost reduction program," Chairman Phillip Frost said in a statement.
via Health News Headlines - Yahoo! News http://news.yahoo.com/teva-pharm-ceo-resigns-cfo-stands-interim-basis-121915571--finance.html
via Health News Headlines - Yahoo! News http://news.yahoo.com/teva-pharm-ceo-resigns-cfo-stands-interim-basis-121915571--finance.html
No comments:
Post a Comment